Compound 2183
Identifiers
- Canonical SMILES:
CC(C)c1cc(ccc1O)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1
- IUPAC name:
4-{2-[4-hydroxy-3-(propan-2-yl)phenyl]diazen-1-yl}-N-(pyridin-2-yl)benzene-1-sulfonamide
- InChi:
InChI=1S/C20H20N4O3S/c1-14(2)18-13-16(8-11-19(18)25)23-22-15-6-9-17(10-7-15)28(26,27)24-20-5-3-4-12-21-20/h3-14,25H,1-2H3,(H,21,24)
- InChiKey:
JNIDFULPZRYKQL-UHFFFAOYSA-N
External links
![]() 136174606 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 396.13 g/mol | |||
HBA | 7 | |||
HBD | 2 | |||
HBA + HBD | 9 | |||
AlogP | 5.19 | |||
TPSA | 101.21 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.8062 | Sulfasalazine | DB00795 | |
0.6518 | Sulfapyridine | DB00891 | |
0.4962 | Sulfaquinoxaline | DB11464 | |
0.4959 | Sulfaperin | DB13320 | |
0.4911 | 2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide | DB07056 | |
0.4833 | Sulfadiazine | DB00359 | |
0.4809 | Sulfamethazine | DB01582 | |
0.4797 | N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE | DB07944 | |
0.4769 | Sulfameter | DB06821 | |
0.4685 | Sulfachlorpyridazine | DB11461 | |
0.4656 | Sulfamerazine | DB01581 | |
0.4623 | Elismetrep | DB15287 | |
0.4605 | Sulfaethoxypyridazine | DB11462 | |
0.4595 | Sulfamethoxypyridazine | DB13773 | |
0.4546 | ABT-751 | DB12254 |